Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.
出版信息
P T. 2010 Jan;35(1 Section 2):2-24.
Abstract
摘要
相似文献
1
Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.
P T. 2010 Jan;35(1 Section 2):2-24.
2
Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction.
Biochim Biophys Acta. 1981 May 29;668(3):456-70. doi: 10.1016/0005-2795(81)90180-x.
3
Macromolecular factor VIII complex: functional and structural heterogeneity observed in von Willebrand swine with transfusion.
Proc Natl Acad Sci U S A. 1977 Feb;74(2):759-63. doi: 10.1073/pnas.74.2.759.
4
In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor.
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619873976. doi: 10.1177/1076029619873976.
5
Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. II. Further purification with thiol-disulfide interchange chromatography and additional evidence for disulfide bonds susceptible to limited reduction.
Biochim Biophys Acta. 1981 May 29;668(3):471-80. doi: 10.1016/0005-2795(81)90181-1.
6
Nature of von Willebrand factor: a new assay and a specific inhibitor.
Proc Natl Acad Sci U S A. 1974 Aug;71(8):2937-41. doi: 10.1073/pnas.71.8.2937.
7
Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.
Proc Natl Acad Sci U S A. 1973 Oct;70(10):2814-8. doi: 10.1073/pnas.70.10.2814.
8
9
Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.
Science. 1973 Dec 14;182(4117):1149-51. doi: 10.1126/science.182.4117.1149.
10
Von Willebrand factor: gene dosage relationships and transfusion response in bleeder swine--a new bioassay.
Proc Natl Acad Sci U S A. 1974 May;71(5):2087-90. doi: 10.1073/pnas.71.5.2087.
本文引用的文献
1
Von Willebrand disease: screening, diagnosis, and management.
Aesthet Surg J. 2008 Mar-Apr;28(2):189-94. doi: 10.1016/j.asj.2007.12.002.
2
Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach.
Blood. 2008 Apr 15;111(8):3998-4003. doi: 10.1182/blood-2007-08-105940. Epub 2008 Jan 10.
3
Management of inherited von Willebrand disease in 2007.
Ann Med. 2007;39(5):346-58. doi: 10.1080/07853890701513738.
4
The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.
Blood. 2007 Jan 1;109(1):145-54. doi: 10.1182/blood-2006-05-021105..
5
Advances in the diagnosis and management of von Willebrand disease.
Hematology. 2006 Aug;11(4):219-25. doi: 10.1080/10245330600841311.
6
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
Blood. 2007 Jan 1;109(1):112-21. doi: 10.1182/blood-2006-05-020784. Epub 2006 Sep 19.
7
Diagnosis of inherited von Willebrand disease: a clinical perspective.
Semin Thromb Hemost. 2006 Sep;32(6):555-65. doi: 10.1055/s-2006-949661.
8
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.
J Thromb Haemost. 2006 Oct;4(10):2103-14. doi: 10.1111/j.1538-7836.2006.02146.x. Epub 2006 Aug 2.
9
Treatment of von Willebrand's Disease.
N Engl J Med. 2004 Aug 12;351(7):683-94. doi: 10.1056/NEJMra040403.
10
Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Blood Coagul Fibrinolysis. 2004 Jun;15(4):323-30. doi: 10.1097/00001721-200406000-00006.
Zotero 插件